Lim wrote a GBM Review Paper after LL did if I remember correct and he cited LL's work but did not say much, imo. But on today's link, he is suggesting DcVaxL as a potential SOC for GBM. It is a great endorsement in my opinion. These MDs are trying to compete and outperform each other and when they speak good of a competing trial, it is an endorsement in my opinion. Ex is not the FDA guy to approve or else a therapy. He is spinning just in front of eyes. Imagine what he wouldn't do when we don't know things.
Market Data 
Markets 
AI
